Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)
Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 50090-7841
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-7841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)
This text provides a comparison of the reduction in CPS (Central Processing System) rate between Divalproex Sodium Delayed-Release Tablets and Placebo. The information includes the percentage of patients showing improvement, no change, or worsening. It gives insights into the effectiveness of Divalproex Sodium in reducing CPS rates compared to Placebo.*
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)
This text contains information about the reduction in CPS rate based on different percentages, including 100%, 75%, 50%, 25%, and the distinction between high and low dose Divalproex Sodium Delayed-Release Tablets for patients. The text also mentions "No Change" and the number of patients represented in the data.*
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)
This text appears to list some numerical values followed by information related to a medication. It includes details about a placebo and Divalproex sodium extended-release tablets. Additionally, there is a notation indicating "p=0.006."*
Logo (546b07bd 7dba 49c9 8caf 7914600d4d19 05)
Label Image (Lbl500907841)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
